Peripheral Arterial Hemorrhage clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Onyx™ Liquid Embolic IDE Clinical Study

    open to eligible people ages 22 years and up

    The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.

    Los Angeles, California and other locations

Our lead scientists for Peripheral Arterial Hemorrhage research studies include .

Last updated: